Hyehyun Jeong
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Clinicopathological Significance of Leucine-rich Repeat-containing 15 in Distal Extrahepatic Bile Duct Carcinoma.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: January 21, 2026
Prognostic implications of body composition changes in patients with non-metastatic pancreatic adenocarcinoma treated with mFOLFIRINOX.
Journal: Frontiers in oncology
Published: December 07, 2025
Molecular epidemiology and outcomes of EGFR exon 20 insertion in Korean patients with non-small cell lung cancer.
Journal: Translational lung cancer research
Published: November 30, 2025
A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast Cancer.
Journal: Journal of breast cancer
Published: October 13, 2025
Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer: A Randomized Clinical Trial.
Journal: JAMA network open
Published: October 01, 2025
Prognostic Significance of Pretreatment ¹⁸F-FDG PET/CT Parameters in Patients With ER+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors Plus Endocrine Therapy.
Journal: Korean journal of radiology
Published: September 23, 2025
Serial analysis of ESR1 mutations in cell-free DNA from hormone receptor-positive, HER2-negative metastatic breast cancer during palliative endocrine therapy.
Journal: Frontiers in oncology
Published: September 20, 2025
Modified FOLFIRINOX with or Without Stereotactic Body Radiation in Locally Advanced Unresectable Pancreatic Cancer (SABER): A Randomized Open-Label Phase 2 Trial.
Journal: Annals of surgical oncology
Published: September 16, 2025
Body composition and immunotherapy outcomes in patients with advanced urothelial carcinoma.
Journal: BMC cancer
Published: June 16, 2025
A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based Chemotherapy.
Journal: Anticancer research
Published: June 10, 2025
Bevacizumab plus Erlotinib in Advanced Solid Cancers with Krebs Cycle Gene Mutations: A Multicenter Phase II Study (BRISK; KCSG AL22-16).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2025
Last Updated: 09/26/2026